are glp-1 biologics Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose among different types of injectables and even GLP-1R and Diabetes

The risk of death among people with diabetes (aged 2059 years) is at least double that in those without diabetes [2]

While tracking weight can motivate, the main goal is to understand how symptoms such as nausea, fatigue, and appetite suppression change throughout the week

Planning for potential coverage disruptions by identifying compounded alternatives in advance prevents forced abrupt discontinuation

JAMA, 327 (2), 138-150

This underscores the potential uniqueness of the observed risks with GLP-1RAs and emphasizes the need for further comparative evaluations to confirm these differential effects

Taking GLP-1s appears to alter these areas and change the levels of reward-related neurotransmitters dopamine and glutamate, a review of related studies suggests